Nonnucleoside reverse transcriptase inhibitors are chemical enhancers of dimerization of the HIV type 1 reverse transcriptase

Overview of attention for article published in Proceedings of the National Academy of Sciences of the United States of America, June 2001

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)
Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

patent: 17 patents

Readers on

mendeley: 28 Mendeley

So far, Altmetric has seen 17 patents that reference this research output.

Tetrahydroquinazoline derivatives as selective cytotoxic agents

Grant US-12558357-B2

United States of America

24 Feb 2026

Pyrimidone derivatives as selective cytotoxic agents against HIV infected cells

Grant US-12258329-B2

United States of America

25 Mar 2025

TETRAHYDROQUINAZOLINE DERIVATIVES AS SELECTIVE CYTOTOXIC AGENTS

Application WO-2025014788-A1

World Intellectual Property Organisation (WIPO)

16 Jan 2025

TETRAHYDROQUINAZOLINE DERIVATIVES AS SELECTIVE CYTOTOXIC AGENTS

Application EP-4259608-A1

European Patent Office

18 Oct 2023

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 13 additional patents.